"..... in relation to safety and toxicity pre-clinical study results on AtremiC."
Usually you wouldn't expect to hear anything on safety or toxicity until completion of the trial, unless there has been an 'adverse event' or finding in regards to safety and toxicity.
I would be slightly concerned by the timing of this announcement if I was holder.
